The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Black Women Turn to One Another as Their Career Paths Suddenly Recede
Black female professionals have seen a steep drop in employment over the last year. They are turning to each other…
Infant Formula Recalled Amid Botulism Investigation
Health agencies asked caregivers to stop using two batches of ByHeart Whole Nutrition Infant Formula after they found an increase…
The First Income Tax in the Persian Gulf Signals a Changing Economic Reality
A plan by Oman is being closely watched by other governments in the region that are preparing for a future…